Another study indicated that nanoparticle-delivered active GSDMD sensitized mammary tumors to anti-PD1 therapy and pyroptosis of less than 15% of tumor cells was sufficient to clear entire tumor grafts by anti-PD1 therapy [34]. This evidence concerns the gene GSDMD and breast cancer.